title: Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.
abstract: Though the total lymphocyte density has been implicated in the pathogenesis of colorectal cancer (CRC), the clinical implications of lymphocyte subsets in CRC patients remain unclear yet. In this study, we used tissue microarrays and immunohistochemistry to evaluate the density of tumor-infiltrating CD4(+) and CD8(+) T cells as well as CD20(+) B cells in the central region and the invasive margin (IM) of tumor tissue from 67 CRC patients and then analyzed the clinical implications. We found that the subsets of tumor-infiltrating lymphocyte had no relationship with patients' age, tumor size, N category, and tumor stage. However, the density of B cells in the tumor center (TC) of colorectal patients in T1/T2 category was much higher than that of patients in T3/T4 category (P = 0.008). In addition, patients in M0 category had a higher density of CD8(+) T cells in the IM but not in the TC compared to patients in M1 category (P = 0.03). Results in this study demonstrate that higher CD8(+) T cell density in the IM of tumor is associated with lower tumor metastasis and higher B cell density in TC is associated with lower tumor T category. The results also suggest that the analysis of infiltrating lymphocyte subsets is important for understanding the detailed mechanisms of tumor pathogenesis and exploring potential interventions for the tumor.
authors.affiliation: Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
authors.forename: Yunmei
authors.initials: Y
authors.lastname: Liao
authors.forename: Juanjuan
authors.initials: J
authors.lastname: Ou
authors.forename: Jia
authors.initials: J
authors.lastname: Deng
authors.forename: Peiliang
authors.initials: P
authors.lastname: Geng
authors.forename: Rui
authors.initials: R
authors.lastname: Zeng
authors.forename: Yi
authors.initials: Y
authors.lastname: Tian
authors.forename: Houjie
authors.initials: H
authors.lastname: Liang
authors.forename: Bing
authors.initials: B
authors.lastname: Ni
authors.forename: Zhihua
authors.initials: Z
authors.lastname: Ruan
mesh_terms: D000368:Aged; D018951:Antigens, CD20 / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D015179:Colorectal Neoplasms / Q000276:immunology* / Q000473:pathology*; D005260:Female; D006801:Humans; D016131:Lymphocyte Subsets / Q000276:immunology / Q000473:pathology*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology* / Q000473:pathology*; D008297:Male; D009362:Neoplasm Metastasis / Q000276:immunology / Q000473:pathology
chemical_list: D018951:Antigens, CD20
references.citation: Clin Dev Immunol. 2010;2010:
references.pmid: 20953324
references.citation: Cancer Res. 2010 Oct 1;70(19):7476-88
references.pmid: 20719885
references.citation: J Leukoc Biol. 2008 Oct;84(4):981-7
references.pmid: 18559950
references.citation: Science. 2006 Sep 29;313(5795):1960-4
references.pmid: 17008531
references.citation: Cancer Res. 2012 Dec 1;72(23):6119-29
references.pmid: 23071066
references.citation: Nat Med. 1998 Jul;4(7):844-7
references.pmid: 9662379
references.citation: J Clin Oncol. 2007 Jun 20;25(18):2586-93
references.pmid: 17577038
references.citation: Cell Immunol. 2012 Sep;279(1):21-4
references.pmid: 23041206
references.citation: Am J Obstet Gynecol. 2004 Nov;191(5):1598-605
references.pmid: 15547530
references.citation: Eur J Cancer. 2005 Nov;41(17):2645-54
references.pmid: 16239109
references.citation: Gynecol Oncol. 2008 Jan;108(1):106-11
references.pmid: 17945335
references.citation: Ann Dermatol. 2013 Feb;25(1):61-6
references.pmid: 23467045
references.citation: Int J Clin Oncol. 2010 Dec;15(6):552-8
references.pmid: 20963618
references.citation: J Clin Pathol. 2002 Sep;55(9):662-8
references.pmid: 12194995
references.citation: Cancer Res. 2008 Jul 1;68(13):5405-13
references.pmid: 18593943
references.citation: Clin Cancer Res. 2012 Jun 15;18(12):3281-92
references.pmid: 22553348
references.citation: Oncoimmunology. 2012 Dec 1;1(9):1623-1625
references.pmid: 23264915
references.citation: Br J Cancer. 2013 Jan 15;108(1):155-62
references.pmid: 23169287
references.citation: Arch Surg. 2012 Apr;147(4):366-72
references.pmid: 22508783
references.citation: Gut. 2012 Aug;61(8):1163-71
references.pmid: 22207629